Efficacy of ALK5 inhibition in myelofibrosis

Overview of attention for article published in JCI Insight, April 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter: 9 X users
patent: 2 patents

facebook: 1 Facebook page

Readers on

mendeley: 41 Mendeley

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 142,676 followers.

RT @doctorpemm: Efficacy of #ALK5 inhibition in myelofibrosis | Yue et al | #MPNSM https://t.co/YPd7KKiKcy

Efficacy of #ALK5 inhibition in myelofibrosis | Yue et al | #MPNSM https://t.co/YPd7KKiKcy

Efficacy of ALK5 inhibition in myelofibrosis. https://t.co/dS2vHmFPWA https://t.co/M9ydNhbCja

RT @jclinicalinvest: On the cover of @JCI_Insight: Inhibition of ALK5 suppresses TGF-β1-driven myelofibrosis https://t.co/rSSHCfTKcT @Moffi…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 5 additional X posts.